Open AccessThe role of pirfenidone in the treatment of interstitial pneumonia with autoimmune features
Author(s) -
Tao Chen,
Qiuhong Li,
Yuan Zhang,
Chengsheng Yin,
Dagen Weng,
Zhou Ying,
Haitao Yang,
Jingyun Shi,
Yanan Chen,
Shuang Ye,
Xiaodong Wang,
Chunyan Wu,
Yi Huang,
Aihong Zhang,
Huiping Li
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/off5n7
Subject(s) - pirfenidone , medicine , dlco , prednisone , pneumonia , idiopathic pulmonary fibrosis , gastroenterology , surgery , diffusing capacity , lung , lung function
No approved pharmacotherapies are available for patients with interstitial pneumonia with autoimmune features (IPAF). In the present work, we aimed to evaluate the efficacy and safety of pirfenidone for the treatment of IPAF.